Literature DB >> 10355652

Primary neuroendocrine carcinomas of the thymus.

K M Klemm1, C A Moran.   

Abstract

Primary neuroendocrine carcinomas of the thymus are rare and comprise a wide spectrum of lesions ranging from well-differentiated to poorly-differentiated neoplasms. The classification of such tumors in the thymus is still controversial. By convention, the better-differentiated examples have been traditionally designated as thymic carcinoids and thought to represent the mediastinal counterpart of carcinoid tumors in other foregut locations. However, recent studies have shown that such neoplasms, when arising in the thymus, exhibit a much more aggressive behavior than those originating at other locations. We therefore consider these lesions to represent fully malignant neoplasms that fall within the spectrum of neuroendocrine carcinomas. The designation of well-, moderately-, or poorly-differentiated thymic neuroendocrine carcinoma is therefore favored for these tumors in the present review. Because such tumors may often adopt unusual morphological appearances, it is important to distinguish them from other more common conditions presenting at this location that may exhibit similar histological features. The clinicopathologic, immunohistochemical, and differential diagnostic features of these tumors in the mediastinum are discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10355652

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  3 in total

Review 1.  Neuroendocrine tumors of the thymus.

Authors:  Pier Luigi Filosso; Enrico Ruffini; Paolo Solidoro; Matteo Roffinella; Paolo Olivo Lausi; Paraskevas Lyberis; Alberto Oliaro; Francesco Guerrera
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 2.  The term "carcinoid" is a misnomer: the evidence based on local invasion.

Authors:  Jun Soga
Journal:  J Exp Clin Cancer Res       Date:  2009-02-10

3.  Clinical outcomes of atypical carcinoid tumors of the lung and thymus: 7-year experience of a rare malignancy at single institute.

Authors:  Boram Han; Jong-Mu Sun; Jin Seok Ahn; Keunchil Park; Myung-Ju Ahn
Journal:  Med Oncol       Date:  2013-02-03       Impact factor: 3.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.